Kulke MH - Search Results

1

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: kulke mh. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

2

Carcinoid tumors.

Kulke MH, Mayer RJ. Kulke MH, et al. N Engl J Med. 1999 Mar 18;340(11):858-68. doi: 10.1056/NEJM199903183401107. N Engl J Med. 1999. PMID: 10080850 Review. No abstract available.

3

Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus-associated adenocarcinoma.

Kulke MH, Thakore KS, Thomas G, Wang H, Loda M, Eng C, Odze RD. Kulke MH, et al. Cancer. 2001 Apr 15;91(8):1451-7. doi: 10.1002/1097-0142(20010415)91:8<1451::aid-cncr1152>3.0.co;2-z. Cancer. 2001. PMID: 11301392

4

Metastatic pancreatic cancer.

Kulke MH. Kulke MH. Curr Treat Options Oncol. 2002 Dec;3(6):449-57. doi: 10.1007/s11864-002-0065-5. Curr Treat Options Oncol. 2002. PMID: 12392635 Review.

5

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

6

Recent developments in the pharmacological treatment of advanced pancreatic cancer.

Kulke MH. Kulke MH. Expert Opin Investig Drugs. 2003 Jun;12(6):983-92. doi: 10.1517/13543784.12.6.983. Expert Opin Investig Drugs. 2003. PMID: 12783602 Review.

7

Neuroendocrine tumours: clinical presentation and management of localized disease.

Kulke MH. Kulke MH. Cancer Treat Rev. 2003 Oct;29(5):363-70. doi: 10.1016/s0305-7372(03)00072-0. Cancer Treat Rev. 2003. PMID: 12972355 Review.

8

A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.

Ryan DP, Clark JW, Kulke MH, Fuchs CS, Earle CC, Enzinger PC, Stuart K, Catarius KJ, Winkelmann J, Mayer RJ. Ryan DP, et al. Among authors: kulke mh. Cancer Invest. 2003;21(4):505-11. doi: 10.1081/cnv-120022359. Cancer Invest. 2003. PMID: 14533439 Clinical Trial.

9

Advanced pancreatic cancer: is there a role for combination therapy?

Kulke MH. Kulke MH. Expert Rev Anticancer Ther. 2003 Oct;3(5):729-39. doi: 10.1586/14737140.3.5.729. Expert Rev Anticancer Ther. 2003. PMID: 14599095 Review.

10

A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Kulke MH, Kim H, Clark JW, Enzinger PC, Lynch TJ, Morgan JA, Vincitore M, Michelini A, Fuchs CS. Kulke MH, et al. Cancer. 2004 Sep 1;101(5):934-9. doi: 10.1002/cncr.20466. Cancer. 2004. PMID: 15329900 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters